Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults.
Ansaldi F, Valle L, de Florentiis D, Parodi V, Murdaca G, Bruzzone B, Durando P, Setti M, Icardi G. Ansaldi F, et al. Among authors: durando p. Hum Vaccin Immunother. 2012 Aug;8(8):1048-52. doi: 10.4161/hv.20347. Epub 2012 Aug 1. Hum Vaccin Immunother. 2012. PMID: 22832261 Free PMC article. Clinical Trial.
Carriage of Streptoccoccus pneumoniae in healthy adults aged 60 years or over in a population with very high and long-lasting pneumococcal conjugate vaccine coverage in children: rationale and perspectives for PCV13 implementation.
Ansaldi F, de Florentiis D, Canepa P, Ceravolo A, Rappazzo E, Iudici R, Martini M, Botti G, Orsi A, Icardi G, Durando P. Ansaldi F, et al. Among authors: durando p. Hum Vaccin Immunother. 2013 Mar;9(3):614-20. doi: 10.4161/hv.23253. Epub 2013 Jan 4. Hum Vaccin Immunother. 2013. PMID: 23292052 Free PMC article.
Head-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60: evaluation of immunogenicity, cross-protection, safety and tolerability.
Ansaldi F, Orsi A, de Florentiis D, Parodi V, Rappazzo E, Coppelli M, Durando P, Icardi G. Ansaldi F, et al. Among authors: durando p. Hum Vaccin Immunother. 2013 Mar;9(3):591-8. doi: 10.4161/hv.23240. Epub 2013 Jan 7. Hum Vaccin Immunother. 2013. PMID: 23295262 Free PMC article. Clinical Trial.
Influenza vaccination among healthcare workers in Italy.
Alicino C, Iudici R, Barberis I, Paganino C, Cacciani R, Zacconi M, Battistini A, Bellina D, Di Bella AM, Talamini A, Sticchi L, Morando A, Ansaldi F, Durando P. Alicino C, et al. Among authors: durando p. Hum Vaccin Immunother. 2015;11(1):95-100. doi: 10.4161/hv.34362. Epub 2014 Nov 1. Hum Vaccin Immunother. 2015. PMID: 25483521 Free PMC article.
Safety and tolerability of 13-valent pneumococcal conjugate vaccine in the elderly.
Durando P, Rosselli R, Cremonesi I, Orsi A, Albanese E, Barberis I, Paganino C, Trucchi C, Martini M, Marensi L, Turello V, Study Group TL, Bregante A, Cacciani R, Iudici R, La Marca D, Pedano L, Petrucci AF, Santolini M, Sbisà V, Zacconi M. Durando P, et al. Hum Vaccin Immunother. 2015;11(1):172-7. doi: 10.4161/hv.34420. Epub 2014 Nov 1. Hum Vaccin Immunother. 2015. PMID: 25483531 Free PMC article.
Vaccine-preventable infections in Systemic Lupus Erythematosus.
Murdaca G, Orsi A, Spanò F, Faccio V, Puppo F, Durando P, Icardi G, Ansaldi F. Murdaca G, et al. Among authors: durando p. Hum Vaccin Immunother. 2016 Mar 3;12(3):632-43. doi: 10.1080/21645515.2015.1107685. Hum Vaccin Immunother. 2016. PMID: 26750996 Free PMC article. Review.
155 results